KING OF PRUSSIA, PA / ACCESSWIRE / May 28, 2019 / Emergent Health Corp. (OTC PINK: EMGE) (the "Company") the…
LOS ANGELES, CA / ACCESSWIRE / May 28, 2018 / Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a…
NEW YORK, NY / ACCESSWIRE / May 28, 2019 / TARA Biosystems, Inc. (TARA), a company offering physiologically relevant human…
FT. MYERS, FL / ACCESSWIRE / May 28, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic…
TAMPA, FL / ACCESSWIRE / May 27, 2019 / Kidney health management industry leader Healthmap Solutions Inc. ("Healthmap" or the…
CALGARY, AB / ACCESSWIRE / May 27, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "The Company") through its wholly owned…
All Proposals Approved SAN FRANCISCO, CA / ACCESSWIRE / May 24, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or…
LEXINGTON, KY / ACCESSWIRE / May 24, 2019 / Medical Vision Institute in Lexington, Kentucky recently discussed cataracts, what causes…
Company will Re-Enter the Employment Market with Oral Fluid Drug Tests KINDERHOOK, NY / ACCESSWIRE / May 24, 2019 /…
Mytesi® Net Sales and Gross Sales Grew 154% and 161%, Respectively, in Q1 2019 Compared to Q1 2018 SAN FRANCISCO,…
ELMSFORD, NY / ACCESSWIRE / May 24, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's…
VANCOUVER, BC / ACCESSWIRE / May 23, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is making…
FT. MYERS, FL / ACCESWIRE / May 23, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic…
SAN DIEGO, CA / ACCESSWIRE / May 23, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront…
CAMBRIDGE, MA and ROSTOCK, GERMANY / May 23, 2019 / CENTOGENE today welcomed Germany's Chancellor Dr. Angela Merkel to its…
Company Plans to Communicate 3rd Offer for the Monitizing Its New "TBG" Products, Developments in Big Box Efforts And the…
BRENTWOOD, TN / ACCESSWIRE / May 23, 2019 / IMAC Holdings, Inc. (NASDAQ: IMAC), a provider of innovative medical advancements…
Presented by Dr. Giovanni Amoroso During the New Solutions for Serious Needs Session of EuroPCR PARIS, FRANCE / ACCESSWIRE /…
Novel 'first in class' IV antibiotic approved for use in Canada. IVOZFO™ (fosfomycin for injection) provides a new option for…
ALACHUA, FL / ACCESSWIRE / May 23, 2019 / CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that…